Erdem, G. U. Et Al. 2016. Comparison of clinical outcomes in patents with early stage ER PR HER2 breast cancer patients with triple negatives. 2016 ASCO Annual Meeting .

Erdem, G. U., AKSOY, S., ŞENDUR, M. A. N., ÖZDEMİR, N., Doğan, M., ZENGİN, N., ... ALTUNDAĞ, M. K.(2016). Comparison of clinical outcomes in patents with early stage ER PR HER2 breast cancer patients with triple negatives . 2016 ASCO Annual Meeting

Erdem, Gökmen Et Al. "Comparison of clinical outcomes in patents with early stage ER PR HER2 breast cancer patients with triple negatives," 2016 ASCO Annual Meeting, 2016

Erdem, Gökmen U. Et Al. "Comparison of clinical outcomes in patents with early stage ER PR HER2 breast cancer patients with triple negatives." 2016 ASCO Annual Meeting , 2016

Erdem, G. U. Et Al. (2016) . "Comparison of clinical outcomes in patents with early stage ER PR HER2 breast cancer patients with triple negatives." 2016 ASCO Annual Meeting .

@conferencepaper{conferencepaper, author={Gökmen Umut Erdem Et Al. }, title={Comparison of clinical outcomes in patents with early stage ER PR HER2 breast cancer patients with triple negatives}, congress name={2016 ASCO Annual Meeting}, city={}, country={}, year={2016}}